The federal appeals court for the District of Columbia
Circuit recently ruled in favor of the Humana Medicare Advantage plan in a case
by a 340B covered
Last week, Apexus published a tool which states for the first time HRSA’s policy that all non-FQHC federal grantees are required to register each of
We are excited to announce that the second RWC-340B national conference will be held in Fort Lauderdale, Florida on January 6-7, 2020. We are especially
Earlier this month, the Alliance
for Integrity and Reform of 340B (“AIR340B”), a national advocacy group funded
largely by pharmaceutical companies, released an update
to their previous reports
Earlier this month, Rep. Mary Gay Scanlon (D-PA) toured the clinic of RWC-340B member AIDS Care Group (ACG), located in Chester, PA. During Rep. Scanlon’s
On October 9, 2019, the White House issued two executive orders with potential implications on HRSA’s ability to enforce its sub-regulatory guidance, including its patient
340B Health reports that Capt. Krista Pedley, the Director of OPA, stated last week at the Medicaid Drug Rebate Conference that OPA is reevaluating its
In a Federal Register notice issued yesterday, CMS announced that it intends to survey hospitals on their acquisition costs for covered outpatient drugs purchased under the 340B
This week, the U.S District Court for the Southern District of Florida granted a motion for stay which paused the lawsuit between Sentry Data Systems
The Centers for Disease Control and Prevention (CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC) has scheduled a public meeting
